Corcept Therapeutics News

Corcept Therapeutics | DEFA14A: Others

Apr 18 17:12 ET

Corcept Therapeutics | ARS: Annual Report to Security Holders

Apr 17 16:45 ET

Corcept Therapeutics | 8-K: Current report

Apr 17 06:09 ET

Corcept Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director MAHONEY DAVID L

Apr 12 19:03 ET

Corcept Therapeutics | DEF 14A: Definitive information statements

Apr 10 16:48 ET

Corcept Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Lyon Joseph Douglas

Apr 8 18:18 ET

Corcept Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Apr 4 12:45 ET

Corcept Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Lyon Joseph Douglas

Apr 3 20:04 ET

Corcept Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Swisher Daniel N JR

Apr 3 19:44 ET

Corcept Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Apr 1 10:06 ET

Corcept Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Maduck Sean

Mar 29 14:17 ET

Corcept Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-INGALLS & SNYDER, LLC(8.0%)

Mar 27 14:35 ET

Corcept Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Mar 27 13:04 ET

Corcept Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Maduck Sean

Mar 20 17:13 ET

Corcept Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Lyon Joseph Douglas

Mar 5 21:24 ET

Corcept Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Maduck Sean

Mar 5 21:19 ET

Corcept Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Guyer William

Mar 5 21:14 ET

Corcept Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Mokari Atabak

Mar 5 21:04 ET

Corcept Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Swisher Daniel N JR

Mar 5 21:04 ET

Corcept Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Robb Gary Charles

Mar 5 20:44 ET